Abstract
Get full access to this article
View all access options for this article.
References
1.
Zech FJD
,
Lehmann KA
,
Grond S
. A new treatment option for chronic cancer pain . Eur J Pall Care
1994 ; 1 : 26 –30 .
2.
Fine PG
,
Streisand JB
. A review of oral transmucosal fentanyl citrate: potent, rapid and noninvasive opioid analgesia . J Pall Med
1998 ; 1 : 55 –63 .
3.
Streisand JB
,
Varvel JR
,
Stanski DR
et al. Absorption and bioavailability of oral transmucosal fentanyl citrate . Anesthesiology
1991 ; 75 : 223 –229 .
4.
Worsley MH
,
MacLeod AD
,
Brodie MJ
,
Asbury AJ
,
Clark C
. Inhaled fentanyl as a method of analgesia . Anaesthesia
1990 ; 45 : 449 –451 .
5.
Striebel HW
,
Koenigs D
,
Krämer J
. Post-operative pain management by intranasal demand-adapted fentanyl titration . Anesthesiology
1992
77 : 281 –285 .
6.
Ahmedzai S
,
Davis C
. Nebulised drugs in palliative care . Thorax
1997 ; 52 (suppl 2 ): S75 –S77 .
7.
Portenoy RK
,
Hagen NA
. Breakthrough pain: definition, prevalence and characteristics . Pain
1990 ; 41 : 273 –281 .
8.
Banning A
,
Sjøgren, Henriksen H
. Treatment outcome in a multidisciplinary cancer pain clinic . Pain
1991 ; 47 : 129 –134 .
9.
Fine PG
,
Busch MA
. Characterization of breakthrough pain by hospice patients and their caregivers . J Pain Symptom Manage
1998 ; 16 : 179 –183 .
10.
Portenoy RK
,
Payne R
,
Coluzzi P
et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study . Pain
1999 ; 79 : 303 –312 .
11.
Clay MM
,
Clarke SW
. Wastage of drug from nebulisers: a review . J R Soc Med
1987 ; 80 : 38 –39 .
12.
Hardy JG
,
Lee SW
,
Wilson CG
. Intranasal drug delivery by spray and drops . J Pharm Pharmacol
1985 ; 37 : 294 –297 .